Company
Headquarters: New Taipei City, Taiwan
Employees: 121
TW$989.8 Million
TWD as of Jan. 1, 2024
US$32.3 Million
| Company | Market Cap (USD) |
|---|---|
| Novo Nordisk | $461.52 B |
| Vertex Pharmaceuticals Incorporated | $107.23 B |
| Regeneron Pharmaceuticals, Inc. | $100.01 B |
| CSL Limited | $94.74 B |
| Marinomed Biotech AG | $73.23 B |
| Company | Market Cap (USD) |
|---|---|
| Lilly | $586.39 B |
| UnitedHealth Group | $504.47 B |
| Novo Nordisk | $461.52 B |
| Johnson & Johnson | $387.50 B |
| Merck | $296.51 B |
Level Biotechnology Inc. markets and distributes cell culture, immunology, and molecular biology products in Taiwan. The company engages in the marketing and distribution of biomedical precision equipment. It provides services in the areas of mammalian and genetic toxicology, pharmacology, biocompatibility, and model animal production. The company offers preclinical research services to the biotech, pharmaceutical, medical device, animal health, and agrichemical industries. Level Biotechnology Inc. was founded in 1989 and is headquartered in New Taipei City, Taiwan.
Top 1-year algo backtest: +269.94%
$10,000 in May 2023 would now be $36,994 by following this algorithm daily at market close.
Boost your stocks returns with Disfold AI... Now!
Try Disfold AI for FREE
Level Biotechnology, Inc. has the following listings and related stock indices.
Stock: TWSE: 3118 wb_incandescent